Cancer Med. 2026 May;15(5):e71956. doi: 10.1002/cam4.71956.
ABSTRACT
PURPOSE: Tobacco smoking adversely affects cancer outcomes; yet tobacco treatment for patients with non-tobacco-related cancers (non-TRCs) remains understudied. This study evaluated smoking behaviors, harm perceptions, and cessation support in this population.
METHODS: We conducted a cross-sectional survey of 124 adults who reported smoking within the past 30 days and were diagnosed with non-TRCs at two medical centers between 2018 and 2022. Data collected included demographics, smoking behaviors, harm perceptions, quit attempts, and receipt of cessation support from oncology providers.
RESULTS: Most participants (88%) recognized that continued smoking may shorten life expectancy; however, fewer recognized its impact on cancer recurrence (44%), treatment efficacy (46%), and treatment-related side effects (46%). Although 81% reported prior quit attempts, only 33% received prescription medication and 22% received counseling. Follow-up support from oncology teams was reported by 42% of participants.
CONCLUSION: Patients with non-TRCs demonstrate substantial gaps in awareness of the cancer-specific harms of continued smoking and report inconsistent receipt of evidence-based cessation support. Targeted education and systematic integration of tobacco treatment into oncology care are needed to improve outcomes in this population.
PMID:42153226 | DOI:10.1002/cam4.71956
